Sionna Therapeutics, Inc.

SION · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
Assets
Cash & Equivalents$38$39$55
Short-Term Investments$110$0$28
Receivables$0$0$0
Inventory$0$0$0
Other Curr. Assets$3$1$1
Total Curr. Assets$151$39$84
Property Plant & Equip (Net)$10$12$3
Goodwill$0$0$0
Intangibles$0$0$0
Long-Term Investments$21$0$0
Tax Assets$0$0$0
Other NC Assets$4$1$1
Total NC Assets$35$13$4
Other Assets$0$0$0
Total Assets$186$52$87
Liabilities
Payables$1$1$1
Short-Term Debt$1$1$0
Tax Payable$0$0$0
Deferred Revenue$0$0$0
Other Curr. Liab.$8$7$8
Total Curr. Liab.$10$8$8
LT Debt$9$10$0
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$330$149$149
Total NC Liab.$339$159$149
Other Liabilities$0$0$0
Cap. Leases$10$10$0
Total Liabilities$349$167$157
Equity
Pref Stock$330$149$149
Common Stock$0$0$0
Retained Earnings-$181-$119-$72
AOCI$0$0-$0
Other Equity-$313-$145-$147
Total Equity-$164-$115-$70
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$186$52$87
Net Debt-$28-$28-$55